The ability of influenza virus to rapidly undergo antigenic shift to evade immunity raises the need for effective influenza antivirals with a broad spectrum. In a recent Nature Microbiology article, ...

Automation and machine learning are transforming antibody discovery at LabGenius, with the EVA™ platform enabling rapid, high ...

CROSS-SPECIES BBB-PENETRANT IV-DELIVERED AAV GENE THERAPY PROVIDES BROAD AND ROBUST CNS TAU LOWERING IN TAUOPATHY MOUSE AND NON-HUMAN PRIMATE. Wencheng Liu, Ph.D., ID:419.

Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.

Nanobodies, or single-domain antibodies, are only about 10% the sizeof traditional antibodies, yet retain high target-binding ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

ProMIS Neurosciences (PMN) announced plans to deliver virtual oral presentations at the 2025 Alzheimer’s and Parkison’s Disease International ...

such as HIV-or accelerate to the "banking" phase to preserve effective antibodies. The team started by mapping B cell lineages with single-cell RNA sequencing, to determine whether various populations ...

In this study, we demonstrated that the design of mimetic antibodies (MA) can be achieved using a combination ... whose genome is a positive single strand RNA (+ssRNA) molecule approximately 30,000 ...